ELANE and lung carcinoma: However, pretreatment with NET inhibitors (anti-NE antibody and DNase) effectively reduced migration (Figures 6(a) and 6(c)) and invasion (Figures 6(b) and 6(d)), which confirmed the ability of NETs to promote migration and invasion of A549 lung cancer cells.